- Home
- CMMB vs GORV Comparison
CMMB vs GORV Comparison
Compare CMMB & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- GORV
- Stock Information
- Founded
- CMMB 2004
- GORV 1976
- Country
- CMMB Israel
- GORV United States
- Employees
- CMMB N/A
- GORV N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- GORV Retail-Auto Dealers and Gas Stations
- Sector
- CMMB Health Care
- GORV Consumer Discretionary
- Exchange
- CMMB Nasdaq
- GORV Nasdaq
- Market Cap
- CMMB 23.6M
- GORV 26.5M
- IPO Year
- CMMB N/A
- GORV 2015
- Fundamental
- Price
- CMMB $1.20
- GORV $0.22
- Analyst Decision
- CMMB Strong Buy
- GORV Hold
- Analyst Count
- CMMB 2
- GORV 2
- Target Price
- CMMB $9.00
- GORV $2.00
- AVG Volume (30 Days)
- CMMB 167.2K
- GORV 156.5K
- Earning Date
- CMMB 05-08-2025
- GORV 05-14-2025
- Dividend Yield
- CMMB N/A
- GORV N/A
- EPS Growth
- CMMB N/A
- GORV N/A
- EPS
- CMMB N/A
- GORV N/A
- Revenue
- CMMB N/A
- GORV $871,562,000.00
- Revenue This Year
- CMMB N/A
- GORV $15.65
- Revenue Next Year
- CMMB N/A
- GORV $20.54
- P/E Ratio
- CMMB N/A
- GORV N/A
- Revenue Growth
- CMMB N/A
- GORV N/A
- 52 Week Low
- CMMB $0.58
- GORV $0.20
- 52 Week High
- CMMB $2.55
- GORV $4.00
- Technical
- Relative Strength Index (RSI)
- CMMB 50.27
- GORV 32.94
- Support Level
- CMMB $1.08
- GORV $0.23
- Resistance Level
- CMMB $1.25
- GORV $0.27
- Average True Range (ATR)
- CMMB 0.11
- GORV 0.04
- MACD
- CMMB 0.04
- GORV 0.01
- Stochastic Oscillator
- CMMB 83.65
- GORV 22.16
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.